Silver nanoparticles exhibit the dose-dependent anti-proliferative effect against human squamous carcinoma cells attenuated in the presence of berberine

Molecules

Volumn 21, Issue 3, 2016, Pages

  Dziedzic, Arkadiusz ^a   Kubina, Robert ^a   Bułdak, Rafał J ^a   Skonieczna, Magda ^b   Cholewa, Krzysztof ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b SILESIAN UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Bax bcl 2 gene expression; Berberine; MTT assay; Oral carcinoma; RT QPCR; SCC 25cell cycle arrest; Silver nanoparticles

Indexed keywords

BERBERINE; METAL NANOPARTICLE; REACTIVE OXYGEN METABOLITE; SILVER;

APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL PROLIFERATION; DRUG EFFECTS; HUMAN; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; BERBERINE; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; METAL NANOPARTICLES; REACTIVE OXYGEN SPECIES; SILVER;

EID: 84963647517     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules21030365     Document Type: Article

References (44)

1. Marur, S.; Forastiere, A.A. Head and neck cancer: changing epidemiology, diagnosis, and treatment. Mayo Clin. Proc. 2008, 83, 489-501. [CrossRef] [PubMed]
2. International Agency for Research on Cancer. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012;World Health Organization: Lyon, France, 2012.
3. Howlader, N.; Noone, A.M.; Krapcho, M.; Garshell, J.; Miller, D.; Altekruse, S.F.; Kosary, C.L.; Yu, M.; Ruhl, J.; Tatalovich, Z.; et al. SEER Cancer Statistics Review, 1975-2011. Bethesda, M.D., Ed.; National Cancer Institute: Bethesda, MD, USA, 2014; Available online: http://seer.cancer.gov/csr/1975-2011 (accessed on 14 March 2016).
4. Amir, Z.; Kwan, S.Y.; Landes, D.; Feber, T.; Williams, S.A. Diagnostic delays in head and neck cancers. Eur. J. Cancer Care 1999, 8, 198-203. [CrossRef]
5. Berrino, F.; Gatta, G. Variation in survival of patients with head and neck cancer in Europe by the site of origin of the tumours. Eur. J. Cancer 1998, 34, 2154-2161. [CrossRef]
6. Conway, D.I.; McKinney, P.A.; McMahon, A.D.; Ahrens, W.; Schmeisser, N.; Benhamou, S.; Bouchardy, C.; Macfarlane, G.J.; Macfarlane, T.V.; Lagiou, P.; et al. Socioeconomic factors associated with risk of upper aerodigestive tract cancer in Europe. Eur. J. Cancer 2010, 46, 588-598. [CrossRef] [PubMed]
7. Besic Gyenge, E.; Darphin, X.; Wirth, A.; Pieles, U.; Walt, H.; Bredell, M.; Maake, C. Uptake and fate of surface modified silica nanoparticles in head and neck squamous cell carcinoma. J. Nanobiotechnol. 2011, 11, 32. [CrossRef] [PubMed]
8. Zhao, Y.; Nalwa, H. Nanotoxicology-Interactions of Nanomaterials with Biological Systems; American Scienfic Publishers: Valencia, CA, USA, 2007.
9. Gwinn, M.R.; Vallyathan, V. Nanoparticles: Health Effects-Pros and Cons. Environ. Health Perspect. 2006, 114, 1818-1825. [CrossRef] [PubMed]
10. Shahverdi, A.R.; Fakhimi, A.; Shahverdi, H.R.; Minaian, S. Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coli. Nanomedicine 2007, 3, 168-171. [CrossRef] [PubMed]
11. Kim, J.S.; Kuk, E.; Yu, K.N.; Kim, J.H.; Park, S.J.; Lee, H.J.; Kim, S.H.; Park, Y.K.; Park, Y.H.; Hwang, C.Y.; et al. Antimicrobial effects of silver nanoparticles. Nanomedicine 2007, 3, 95-101. [CrossRef] [PubMed]
12. Lansdown, A.B. Silver in health care: antimicrobial effects and safety in use. Dermatology 2006, 33, 17-34.
13. Farmer, L.; Graff, A.; Szameit, S.; Valic, E.; Tuschl, H. Toxicological investigation of nanoparticles: Effects on human cells. 13th Scientific Symposium of the Austrian Pharmacological Society (APHAR). Joint Meeting with the Austrian Society of Toxicology (ASTOX) and the Hungarian Society for Experimental and Clinical Pharmacology (MFT) Vienna, Austria. 2224 November 2007. BMC Pharmacol. 2007, 7, A55. Available online: http://www.vitrocell.com/portals/0/news/publications/poster-nanoparticles-farmer.pdf (accessed on 14 March 2016).
14. Sturgis, E.M.; Moore, B.A.; Glisson, B.S.; Kies, M.S.; Shin, D.M.; Byers, R.M. Neoadjuvant chemotherapy for squamous cell carcinoma of the oral tongue in young adults: A case series. Head Neck 2005, 27, 748-756. [CrossRef] [PubMed]
15. Kim, D.W.; Hong, G.H.; Lee, H.H.; Choi, S.H.; Chun, B.G.; Won, C.K.; Hwang, I.K.; Won, M.H. Effect of colloidal silver against the cytotoxicity of hydrogen peroxide and naphthazarin on primary cultured cortical astrocytes. Neuroscience 2007, 117, 387-400. [CrossRef] [PubMed]
16. Braydich-Stolle, L.; Hussain, S.; Schlager, J.J.; Hofmann, M.C. In Vitro Cytotoxicity of Nanoparticles in Mammalian Germline Stem Cells. Toxicol. Sci. 2005, 88, 412-419. [CrossRef] [PubMed]
17. Ahamed, M.; Karns, M.; Goodson, M.; Rowe, J.; Hussain, S.M.; Schlager, J.J.; Hong, Y. DNA damage response to different surface chemistry of silver nanoparticles in mammalian cells. Toxicol. Appl. Pharmacol. 2008, 233, 404-410. [CrossRef] [PubMed]
18. Foldbjerg, R.; Olesen, P.; Hougaard, M.; Dang, D.A.; Hoffmann, H.J.; Autrup, H. PVP-coated silver nanoparticles and silver ions induce reactive oxygen species, apoptosis and necrosis in THP-1 monocytes. Toxicol. Lett. 2009, 190, 156-162. [CrossRef] [PubMed]
19. Chairuangkitti, P.; Lawanprasert, S.; Roytrakul, S.; Aueviriyavit, S.; Phummiratch, D.; Kulthong, K.; Chanvorachote, P.; Maniratanachote, R. Silver nanoparticles induce toxicity in A549 cells via ROS-dependent and ROS-independent pathways. Toxicol. In Vitro 2012, 27, 330-338. [CrossRef] [PubMed]
20. Ho, Y.T.; Lu, C.C.; Yang, J.S.; Chiang, J.H.; Li, T.C.; Ip, S.W.; Hsia, T.C.; Liao, C.L.; Lin, J.G.; Wood, W.G.; et al. Berberine induced apoptosis via promoting the expression of caspase-8, -9 and -3, apoptosis-inducing factor and endonuclease G in SCC-4 human tongue squamous carcinoma cancer cells. Anticancer Res. 2009, 29, 4063-4070. [PubMed]
21. Ho, Y.T.; Yang, J.S.; Li, T.C.; Lin, J.J.; Lin, J.G.; Lai, K.C.; Ma, C.Y.; Wood, W.G.; Chung, J.G. Berberine suppresses in vitro migration and invasion of human SCC-4 tongue squamous cancer cells through the inhibitions of FAK, IKK, NF-kappaB, u-PA and MMP-2 and -9. Cancer Lett. 2009, 279, 155-162. [CrossRef] [PubMed]
22. Seo, Y.S.; Yim, M.J.; Kim, B.H.; Kang, K.R.; Lee, S.Y.; Oh, J.S.; You, J.S.; Kim, S.G.; Yu, S.J.; Lee, G.J.; et al. Berberine-induced anticancer activities in FaDu head and neck squamous cell carcinoma cells. Oncol. Rep. 2015, 25, 3025-3034. [CrossRef] [PubMed]
23. Gurunathan, S.; Han, J.W.; Eppakayala, V.; Jeyaraj, M.; Kim, J.H. Cytotoxicity of biologically synthesized silver nanoparticles in MDA-MB-231 human breast cancer cells. Biomed. Res. Int. 2013, 2013, 535796. [CrossRef] [PubMed]
24. Franco-Molina, M.A.; Mendoza-Gamboa, E.; Sierra-Rivera, C.A.; Gómez-Flores, R.A.; Zapata-Benavides, P.; Castillo-Tello, P.; Alcocer-González, J.M.; Miranda-Hernández, D.F.; Tamez-Guerra, R.S.; Rodríguez-Padilla, C. Antitumor activity of colloidal silver on MCF-7 human breast cancer cells. J. Exp. Clin. Cancer Res. 2010, 16, 148. [CrossRef] [PubMed]
25. AshaRani, P.V.; Prakash Hande, M.; Valiyaveettil, S. Anti-proliferative activity of silver nanoparticles. BMC Cell Biol. 2009, 10, 65. [CrossRef] [PubMed]
26. Guo, D.; Zhao, Y.; Zhang, Y.; Wang, Q.; Huang, Z.; Ding, Q.; Guo, Z.; Zhou, X.; Zhu, L.; Gu, N. The cellular uptake and cytotoxic effect of silver nanoparticles on chronic myeloid leukemia cells. J. Biomed. Nanotechnol. 2014, 10, 669-678. [CrossRef] [PubMed]
27. Baharara, J.; Namvar, F.; Ramezani, T.; Mousavi, M.; Mohamad, R. Silver Nanoparticles Biosynthesized Using Achillea biebersteinii Flower Extract: Apoptosis Induction in MCF-7 Cells via Caspase Activation and Regulation of Bax and Bcl-2 Gene Expression. Molecules 2015, 20, 2693-2706. [CrossRef] [PubMed]
28. Eom, H.J.; Choi, J. p38 MAPK activation, DNA damage, cell cycle arrest and apoptosis as mechanisms of toxicity of silver nanoparticles in Jurkat T cells. Environ. Sci. Technol. 2010, 44, 8337-8342. [CrossRef] [PubMed]
29. 2-induced apoptosis via calcineurin pathways. J. Bioenerg. Biomembr. 2007, 39, 186-194. [CrossRef] [PubMed]
30. Zeng, G.; Shen, H.; Tang, G.; Cai, X.; Bi, L.; Sun, B.; Yang, Y.; Xun, W. A polysaccharide from the alkaline extract of Glycyrrhiza inflata induces apoptosis of human oral cancer SCC-25 cells via mitochondrial pathway. Tumour. Biol. 2015, 36, 6781-6788. [CrossRef] [PubMed]
31. Andrews, G.A.; Xi, S.; Pomerantz, R.G.; Lin, C.J.; Gooding, W.E.; Wentzel, A.L.; Wu, L.; Sidransky, D.; Grandis, J.R. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis. Head Neck 2004, 26, 870-877. [CrossRef] [PubMed]
32. Jeyaraj, M.; Renganathan, A.; Sathishkumar, G.; Ganapathi, A.; Premkumar, K. Biogenic metal nanoformulations induce Bax/Bcl2 and caspase mediated mitochondrial dysfunction in human breast cancer cells (MCF-7). RSC Adv. 2015, 5, 2159-2166. [CrossRef]
33. Ling, J.; Sang, Y.; Huang, C.Z. Visual colorimetric detection of berberine hydrochloride with silver nanoparticles. J. Pharm. Biomed. Anal. 2008, 47, 860-864. [CrossRef] [PubMed]
34. Jabbarzadeh Kaboli, P.; Rahmat, A.; Ismail, P.; Ling, K.H. Targets and mechanisms of berberine, a natural drug with potential to treat cancer with special focus on breast cancer. Eur. J. Pharmacol. 2014, 740, 584-595. [CrossRef] [PubMed]
35. Jiao, Z.H.; Li, M.; Feng, Y.X.; Shi, J.C.; Zhang, J.; Shao, B. Hormesis Effects of Silver Nanoparticles at Non-Cytotoxic Doses to Human Hepatoma Cells. PLoS ONE 2014, 9, e102564. [CrossRef] [PubMed]
36. Rosarin, F.S.; Arulmozhi, V.; Nagarajan, S.; Mirunalini, S. Antiproliferative effect of silver nanoparticles synthesized using amla on Hep2 cell line. Asian Pac. J. Trop. Med. 2013, 6, 1-10. [CrossRef]
37. El Badawy, A.M.; Silva, R.G.; Morris, B.; Scheckel, K.G.; Suidan, M.T.; Tolaymat, T.M. Surface charge-dependent toxicity of silver nanoparticles. Environ. Sci. Technol. 2011, 45, 283-287. [CrossRef] [PubMed]
38. Chang, J.S.; Chang, K.L.; Hwang, D.F.; Kong, Z.L. In vitro cytotoxicitiy of silica nanoparticles at high concentrations strongly depends on the metabolic activity type of the cell line. Environ. Sci. Technol. 2007, 41, 2064-2068. [CrossRef] [PubMed]
39. Castiglioni, S.; Cazzaniga, A.; Perotta, C.; Maier, J.A. Silver Nanoparticles-induced cytotoxicity requires ERK activation in human bladder carcinoma cells. Toxicol. Lett. 2015, 273, 237-243. [CrossRef] [PubMed]
40. Verma, A.; Stellacci, F. Effect of surface properties on nanoparticle-cell interactions. Small 2010, 6, 12-21. [CrossRef] [PubMed]
41. Ge, L.; Li, Q.; Wang, M.; Ouyang, J.; Li, X.; Xing, M.M. Nanosilver particles in medical applications: synthesis, performance, and toxicity. Int. J. Nanomed. 2014, 16, 2399-2407.
42. Castiglioni, S.; Caspani, C.; Cazzaniga, A.; Maier, J.A. Short- and long-term effects of silver nanoparticles on human microvascular endothelial cells. World J. Biol. Chem. 2014, 5, 457-464. [CrossRef] [PubMed]
43. Specification Sheet. Sigma-Aldrich. Silver, Dispersion. EC Number: 231-791-2. Available online: http://www.sigmaaldrich.com/catalog/product/aldrich/730785?lang=pl®ion=PL (accessed on 14 March 2016).
44. Specification Sheet. MDL number: MFCD00003397. Available online: http://www.sigmaaldrich.com/Graphics/COfAInfo/SigmaSAPQM/SPEC/73/730785/730785-BULK-ALDRICH-.pdf (accessed on 14 March 2016).